ARG1 and chronic myelogenous leukemia, BCR-ABL1 positive: We have demonstrated that in CML patients at diagnosis, G-MDSC is the most abundant subpopulation; it correlates with the percentage of T-reg and up-regulates ARG1 as mediator of the immunosuppressive action [13].